Skip to main content
. 2021 Sep 30;13(10):1587. doi: 10.3390/pharmaceutics13101587

Figure 3.

Figure 3

Proportion of patients achieving biochemical remission at weeks 8, 16, 24 and 32, with standard treatment (■), treatment with initial induction, followed by maintenance dosing every four weeks from week 4 (●) and induction dosing every eight weeks (▲).